Author:
Mego M,Svetlovska D,Angelis V De,Kalavska K,Lesko P,Makovník M,Obertova J,Orszaghova Z,Palacka P,Rečková M,Rejlekova K,Z Sycova-Mila,Mardiak J,Chovanec M
Funder
VEGA
Slovak Research and Development Agency
Ministry of Health, Slovakia
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference32 articles.
1. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8(11):1777–1781. doi:https://doi.org/10.1200/JCO.1990.8.11.1777
2. Lorch A, Kleinhans A, Kramar A, Kollmannsberger CK, Hartmann JT, Bokemeyer C, Rick O, Beyer J (2012) Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. J Clin Oncol 30(8):800–805. doi:https://doi.org/10.1200/JCO.2011.38.6391
3. Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ, Motzer RJ (2005) Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23(27):6549–6555. doi:https://doi.org/10.1200/JCO.2005.19.638
4. Mardiak J, Salek T, Sycova-Mila Z, Obertova J, Hlavata Z, Mego M, Reckova M, Koza I (2005) Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study. Neoplasma 52(6):497–501
5. Mead GM, Cullen MH, Huddart R, Harper P, Rustin GJ, Cook PA, Stenning SP, Mason M, Party MRCTTW (2005) A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial. Br J Cancer 93(2):178–184. doi:https://doi.org/10.1038/sj.bjc.6602682
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献